Evidence map›Paper›PMID 40486071›Full record

ReviewBJR open2025

Imaging patterns and recommendations for diagnosis, staging, and management of lung cancer.

Nivedita Chakrabarty, Abhishek Mahajan, Nitin Shetty, Naveen Mummudi, Devyani Niyogi, Falguni Hota, Deepak Dabkara, Reefath Jebraj, Nilendu Purandare, Vanita Noronha and 2 more

Abstract readReview
In one paragraph

Review in BJR open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nivedita ChakrabartyDepartment of Radiodiagnosis, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.ORCID https://orcid.org/0000-0003-4569-0693
Abhishek MahajanDepartment of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, L7 8YA Liverpool, UK.ORCID https://orcid.org/0000-0001-6606-6537
Nitin ShettyDepartment of Radiodiagnosis and Interventional Radiology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
Naveen MummudiDepartment of Radiation Oncology, Tata Memorial Centre, Tata memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.ORCID https://orcid.org/0000-0002-6083-9225
Devyani NiyogiDepartment of Surgical Oncology, Tata Memorial Centre, Tata memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
Falguni HotaDepartment of Interventional Radiology, Tata Memorial Centre, Tata memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
Deepak DabkaraDepartment of Medical Oncology, Tata Medical Center, Rajarhat, Kolkata 700 160, West Bengal, India.
Reefath JebrajDepartment of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
Nilendu PurandareDepartment of Nuclear Medicine and Molecular Imaging, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai, Maharashtra 400 012, India.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai 400 012, Maharashtra, India.ORCID https://orcid.org/0000-0002-0191-2744
Ashu BhallaDepartment of Radiology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Parel, Mumbai 400 012, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the second most commonly diagnosed cancer worldwide. In the present era of targeted therapy for various lung cancer mutations, it is essential to be aware of the imaging correlates of various lung cancer mutations on contrast enhanced computed tomography of thorax. In this article, we have discussed the imaging patterns of various types of lung cancer including different mutations and also comprehensively reviewed the imaging recommendations (National Comprehensive Cancer Network [NCCN], European Society of Medical Oncology [ESMO] and American Society of Clinical Oncology [ASCO]) and management guidelines of lung cancer (non-small cell, small cell and other neuroendocrine tumours). We have also discussed guidelines for screening, diagnosis, staging (recent 9th edition tumour node metastasis [TNM]), treatment response evaluation, and follow up. Role of interventional radiology in the treatment of primary lung cancer, lung metastasis, and management of posttreatment complications, have also been described in detail in this article. In addition, current status of artificial intelligence in lung cancer has also been briefly discussed.

Indexed as

ASCOESMOimaging guidelinesimaging patternsinterventional radiologylung cancerNCCN

Identifiers

PMID40486071
PMCPMC12145177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.